✓ Medically reviewed by · Last reviewed: May 2026
Pharmacy Researcher · 8 years experience
Pharmacy researcher with 8 years reviewing clinical drug information, generic formulation equivalence, and international pharmaceutical standards. Focuses on patient-facing accuracy in medication education.
💡 Quick Answer
Janumet (sitagliptin + metformin) is a fixed-dose combination tablet for type 2 diabetes. It works through two complementary mechanisms: metformin reduces hepatic glucose output and improves insulin sensitivity; sitagliptin (a DPP-4 inhibitor) boosts the body’s own incretin hormones to stimulate insulin release and suppress glucagon. Together they lower HbA1c by an additional 1.5–2.1% vs either drug alone. Available in 50/500 mg and 50/1000 mg strengths.
📦 Every order is covered by our Reshipment Assurance Policy — if your parcel does not arrive within 20 business days, we reship it.
What Is Janumet?
Janumet is a fixed-dose combination tablet developed by Merck (MSD) containing two active ingredients:
- Sitagliptin — a DPP-4 (dipeptidyl peptidase-4) inhibitor
- Metformin hydrochloride — a biguanide, the most widely prescribed T2DM first-line agent
The combination allows patients who require both drugs to take a single tablet twice daily rather than separate medications, improving adherence and simplifying the regimen.
Key Takeaways
- Generic name: sitagliptin / metformin hydrochloride
- Strengths: Janumet 50/500 mg and Janumet 50/1000 mg
- Dosing: twice daily with meals
- HbA1c reduction: ~1.5–2.1% beyond metformin monotherapy
- Weight: weight-neutral (unlike sulfonylureas, which cause weight gain)
- Hypoglycaemia risk: very low when used without insulin or sulfonylurea
How Janumet Works: Two Complementary Mechanisms
Metformin (biguanide component)
Metformin acts primarily by reducing hepatic glucose production — the liver in T2DM chronically over-releases glucose overnight and between meals. It also improves peripheral insulin sensitivity in muscle, reduces intestinal glucose absorption, and activates AMPK (an energy-sensing enzyme), leading to modest weight-neutral or weight-lowering effects. It does not stimulate insulin secretion and therefore has a very low intrinsic hypoglycaemia risk.
Sitagliptin (DPP-4 inhibitor component)
After eating, the gut releases GLP-1 and GIP — two incretin hormones that stimulate insulin secretion from beta cells and suppress glucagon from alpha cells. In T2DM, this response is blunted. Sitagliptin inhibits DPP-4, the enzyme that breaks down GLP-1 and GIP, extending their half-life and amplifying their effect.
Crucially, the incretin effect is glucose-dependent — sitagliptin only stimulates insulin when glucose is actually elevated. This is why the combination carries very low hypoglycaemia risk compared to sulfonylureas (which push insulin release regardless of glucose level).
Who Is Janumet For?
Who is this for?
- Adults with type 2 diabetes not adequately controlled on metformin alone
- Patients already taking sitagliptin and metformin as separate tablets who want to simplify to one combination pill
- T2DM patients where a sulfonylurea is unsuitable (e.g. risk of hypoglycaemia, weight concerns)
- Patients who need an alternative add-on to metformin when GLP-1 agonists or SGLT2 inhibitors are not appropriate
Janumet is not for type 1 diabetes or diabetic ketoacidosis.
Janumet Dosage Guide
| Strength | Sitagliptin / Metformin | Typical dosing | Best for |
|---|---|---|---|
| Janumet 50/500 | 50 mg / 500 mg | 1 tablet twice daily with meals | Starting dose or lower metformin tolerability |
| Janumet 50/1000 | 50 mg / 1000 mg | 1 tablet twice daily with meals | Established patients already tolerating 1000 mg metformin |
Total daily sitagliptin dose = 100 mg (equivalent to one Januvia/Ristaben tablet). Total daily metformin = 1,000 mg (50/500 twice daily) or 2,000 mg (50/1000 twice daily).
Always take Janumet with meals — this is not optional. Taking metformin-containing products on an empty stomach is the most common reason for the nausea and diarrhoea that patients mistakenly attribute to the drug itself. With food, GI tolerance is substantially better.
Side Effects
The side-effect profile reflects both components:
Metformin-related
- GI effects (most common): nausea, diarrhoea, abdominal pain — almost always dose-related and improve over 2–4 weeks; taking with food reduces this significantly
- Metallic taste — temporary, resolves
- Vitamin B12 depletion — with long-term use; annual B12 monitoring recommended if symptomatic neuropathy develops
- Lactic acidosis — very rare (<1 in 30,000 patient-years) but serious; risk is almost entirely limited to patients with severe renal impairment (eGFR <30), acute illness, or IV contrast exposure. Discontinue before contrast procedures
Sitagliptin-related
- Nasopharyngitis (upper respiratory tract symptoms) — common but mild
- Pancreatitis — rare; discontinue if severe abdominal pain develops; do not restart
- Arthralgias — joint pain reported with DPP-4 inhibitors; can be severe; usually resolves on stopping
- Skin reactions — bullous pemphigoid reported with long-term DPP-4 use
Contraindications and Cautions
| Contraindication | Reason |
|---|---|
| eGFR <30 mL/min/1.73m² | Metformin accumulation → lactic acidosis risk |
| Iodinated contrast procedures | Pause metformin for 48 h before/after; restart when renal function confirmed stable |
| Acute hepatic disease | Impaired lactate clearance increases lactic acidosis risk |
| History of pancreatitis | Sitagliptin associated with pancreatitis risk; use alternative |
Janumet vs Janumet XR vs Separate Tablets
| Option | Frequency | GI tolerability | Notes |
|---|---|---|---|
| Janumet (IR) | Twice daily with meals | Good with food | Standard; most widely available |
| Janumet XR (ER) | Once daily with evening meal | Better for GI-sensitive patients | Extended-release metformin; less nausea; do not crush or chew |
| Sitagliptin + Glycomet SR (separate) | Variable | SR metformin better tolerated | Glycomet SR is a cost-effective metformin SR option; Janumet combines both for convenience |
Janumet in Practice: What to Expect
First 2–4 weeks: Some GI discomfort (nausea, loose stools) — take strictly with food, start with 50/500 if new to metformin. Symptoms settle as the gut adapts.
By 8–12 weeks: HbA1c reduction becomes measurable. Typical response: 1.5–2.1% reduction from baseline. Weight is usually stable or slightly reduced (unlike sulfonylureas, which add 1–3 kg).
Ongoing: eGFR should be monitored annually (every 6 months if borderline). Sitagliptin dose adjustment is required if eGFR falls to 30–44 (use sitagliptin 50 mg monotherapy; Janumet is contraindicated). B12 levels checked if peripheral neuropathy symptoms emerge.
Frequently Asked Questions
What is “janument”?
Janument is a common misspelling of Janumet (sitagliptin/metformin) — same medication. The correct brand name is Janumet, made by Merck/MSD.
Does Janumet cause weight loss or weight gain?
Janumet is weight-neutral on average. Unlike sulfonylureas (which cause 1–3 kg weight gain via increased insulin) or GLP-1 agonists (which cause 3–6 kg weight loss), most patients maintain their baseline weight on Janumet. Some experience modest loss due to the metformin component’s appetite effects, but this varies.
Can Janumet cause hypoglycaemia?
On its own, Janumet carries very low hypoglycaemia risk — both metformin and sitagliptin are glucose-dependent in their mechanism and do not push insulin release when blood glucose is normal. Risk increases significantly if Janumet is combined with a sulfonylurea or insulin — in those combinations, carry fast-acting glucose.
Can I take Janumet with Jardiance (empagliflozin)?
Yes — Janumet and SGLT2 inhibitors like Jardiance are commonly combined because they work through complementary mechanisms (metformin + DPP-4 inhibitor + SGLT2 inhibitor). This triple combination has cardiovascular and renal benefits supported by clinical trial data. Discuss with your clinician for appropriate dose titration.
How long does Janumet take to work?
Blood glucose improvements start within 1–2 weeks of starting. A meaningful reduction in HbA1c (the 3-month average) becomes measurable after 8–12 weeks. Full stabilisation of glycaemic control typically takes 3–6 months at a consistent dose.
Where can I buy Janumet online?
Janumet (sitagliptin/metformin) is available from MedsBase without a prescription requirement. Orders ship worldwide in discreet packaging with no medication name on the exterior. Payment by card, crypto, or SEPA bank transfer.
Medical Disclaimer
This article is for informational purposes only. Type 2 diabetes management requires regular monitoring of blood glucose, HbA1c, and kidney function. Metformin must be paused before iodinated contrast procedures. Consult a healthcare professional before starting, changing, or stopping any diabetes medication.
Why order from MedsBase
Our generic medications are sourced from WHO-GMP certified manufacturers and shipped worldwide in discreet, plain packaging — no medication name on the parcel exterior. Card payments are routed through a regulated processor (statement descriptors include a regulated card-payment processor — never “MedsBase” or any medication name). Crypto and SEPA bank transfer are also accepted. Every order is backed by our Reshipment Assurance Policy.
Written by
Sophie ChenPharmaceutical Content Researcher · 8 years experience
Sophie Chen is a pharmaceutical content researcher with 8 years covering generic medication access and clinical pharmacology. She specialises in international regulatory frameworks, bioequivalence standards, and patient-facing education on therapeutic drug classes. She is not a clinician.